AlivaMab discovery services expands discovery agreement with IGM Biosciences


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Latest pharma news updates

AlivaMab Discovery Services (“ADS”), a leader in the discovery of superior antibody therapeutics, announced an expanded agreement with IGM Biosciences (“IGM”). ADS will rapidly discover diverse panels of human antibodies for the development of engineered antibody-based therapeutics by IGM. The multi-target agreement occurs after the successful conclusion of a pilot project in which ADS identified and delivered to IGM a panel of combinatorially diverse, potently functional, high-affinity antibodies in less than three months.

“With next-generation therapeutic antibody modalities, obtaining a large number of diverse, functionally confirmed antibodies for engineering into the final product is essential to achieve the ultimate functional and developability design goals,” said Justin Mika, CEO of AlivaMab Discovery Services.

The ADS team, with over a century of total experience in antibody drug discovery, engineering and development, has created discovery platforms that deliver molecularly diverse, drug-quality human antibodies with unsurpassed speed and efficiency. By combining the ADS team's deep experience and know-how with a battery of customized, high-throughput discovery strategies, including function-first screening, ADS shortens timelines and increases the quantity and diversity of antibodies that meet or exceed project design goals."

Tags : #Alivamab #IGMBiosciences #PharmaCollaboration

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026